Salivary Testosterone Levels Research Articles

Salivary testosterone levels in women with systemic lupus erythematosus.

To measure salivary testosterone in women with systemic lupus erythematosus (SLE). We investigated concentrations of salivary testosterone in 13 women with active SLE and 47 women with inactive SLE, and in 72 healthy female controls. We found a significant decrease in salivary testosterone concentrations in glucocorticoid-treated SLE patients (mean +/- SD 0.06 +/- 0.04 nmoles/liter) but no differences in concentrations in untreated patients (0.09 +/- 0.03 nmoles/liter), compared with the healthy controls (0.11 +/- 0.04 nmoles/liter). Glucocorticoid treatment appears to cause a decrease in the salivary testosterone level. Measurement of salivary testosterone is a simple way of monitoring androgen metabolism in patients with SLE.

Salivary testosterone and creative musical behavior in adolescent males and females

In a longitudinal study, salivary testosterone levels were assessed in 3 subsequent years in adolescent boys and girls who had documented creative musical talent in their early teens. Decrease of creative musical behavior in adolescent boys was attributed, inter alia, to a testosterone increase exceeding a hypothesized optimal testosterone range for the expression of creative musical behavior. Left‐handers, especially left‐handed boys, were superior to righthanders on a test measuring musical talent. Testosterone levels did not differ between the handedness groups. Sex differences in salivary testosterone were not observed by a mean age of 13.5. Age was more important than mutation in boys and menarche in girls with respect to testosterone rises during puberty. Circadian rhythm in salivary testosterone levels was found in both sexes.

Salivary Testosterone Concentrations in Prepubertal and Pubertal Males: Comparison with Total and Free Plasma Testosterone

Salivary testosterone (T) levels in male children and adolescents were measured and compared with plasma T. Salivary concentrations correlated well with plasma total T (r = 0.72) and even better with free plasma T (r = 0.89) in subjects with plasma T levels of pubertal or adult levels (greater than 1.0 nmol/l). In subjects with prepubertal or low plasma T (less than 1.0 nmol/l), there was neither a correlation with plasma total, nor with free T. In hCG tests (responder and nonresponder), salivary T reflected plasma levels faithfully. The results suggest that salivary T, which is suitable for repeated sampling, is a good marker of T secretion in pubertal males.

Testicular responsiveness to hCG during infancy measured by salivary testosterone

To investigate the role of gonadotropins in postnatal testicular activation, testosterone responsiveness to human chorionic gonadotropin was studied in 11 male infants (aged 5-180 days). The boys were given a single im injection of 5000 IU/1.7m2 hCG, and serum and salivary testosterone responses were then measured for 7 days. The results were compared with the serum testosterone responses of 8 older prepubertal boys (aged 1.7-10.4 years) studied with the same protocol. The mean (+/- SEM) basal serum testosterone levels were 2.67 +/- 1.27 nmol/l in the infants and 0.09 +/- 0.02 nmol/l in the prepubertal boys (p less than 0.05). Both groups gave a significant response to hCG stimulation (p less than 0.001, ANOVA, one-way). The stimulated concentrations of serum testosterone were higher in the infants than in the prepubertal boys (p less than 0.001). The mean basal level of salivary testosterone was 30.5 +/- 7.0 and the mean maximal level was 97 +/- 10.3 pmol/l in the infants (p less than 0.001). No age-related changes were observed in either basal or hCG-stimulated levels. In infants the mean (+/- SEM) maximal hCG-stimulated increase was 25 +/- 10-fold in serum and 8 +/- 4-fold in saliva (p = 0.13). A clear stimulatory effect of hCG on testicular testosterone production was found, suggesting that the postnatal increase in serum testosterone concentration in male infants is gonadotropin-mediated. Salivary testosterone concentrations can be increased by hCG, indicating that measurements of salivary testosterone may provide an optional, non-invasive method for assessing gonadal function in children.

The monitoring of the menstrual status of female athletes by salivary steroid determination and ultrasonography

This study was designed to evaluate whether traditional plasma hormone determinations can be adequately replaced by measurements of salivary hormones. Eleven young sportswomen with menstrual irregularities attributed to strenuous physical exercise participated in this study. Mean body weight expressed as a percentage of ideal body weight was 92%, SD 4%. Their mean weekly training distance was 35 km, SD 15. Basal plasma endocrinological measurements revealed a hypo-oestrogenic status (mean plasma oestradiol values: 22 pg.ml-1, SD 8.8), and a deficient luteal phase (mean plasma progesterone: 2.9 ng.ml-1, SD 2.1). Pre-exercise salivary sex steroids were low. Salivary progesterone levels were 39.3 pg.ml-1, SD 9.5 (normal ranges in saliva: 25-60 pg.ml-1), salivary oestrone (E1) was 12.2 pg.ml-1, SD 2.3 (normal ranges in saliva: 7.5-25 pg.ml-1), and salivary oestradiol (E2) less than 1.9 pg.ml-1, SD 1.1 (normally 1.0-10.0 pg.ml-1). After a 21-km run, all salivary steroids appeared to increase. Mean salivary testosterone levels increased by 15.2% and salivary progesterone by 14.8%. Mean salivary oestrogens also increased (E1: +13.9%; E2: +21.1%). These findings confirm the results of earlier studies which found higher post-exercise plasma sex steroid levels. Since salivary measurements are believed to reflect non-protein-bound, thus free steroid levels, the results obtained by these techniques may provide a more realistic picture of the hormonal effects of physical exercise. In future, more accurate, cost-effective and easier techniques for salivary measurements may offer additional advantages.

Salivary testosterone in cryptorchid pubertal boys: a parameter to assess the gonadal function

The authors studied salivary and serum testosterone (T) levels in basal conditions and at 6 and 12 months after orchidopexy in 36 pubertal boys with unilateral or bilateral cryptorchidism. Boys were divided into two groups according to Tanner classification. Salivary and serum T levels were significantly lower in the group with scanty or absent sexual development than those obtained in the group with normal development. Both groups exhibited similar saliva and serum testosterone values at 12 months of the follow-up study. The data shown indicate that salivary T seems a good index for evaluating the androgenic status of these patients.

Salivary testosterone levels and the progress of puberty in the normal boy.

Salivary testosterone (ST) levels were measured in 84 boys aged 7.3-16.2 from the Edinburgh Growth Study. The correlation coefficient between matched plasma/saliva samples was 0.88. Six samples were collected over the course of one day from 0900 to 2100 h each month in the majority of the children for 4 consecutive months. Mean daily ST levels showed a significant rise between each pubertal stage (genital (G) and pubic hair (PH]. The rise in ST became more rapid once a mean testicular volume (MTV) of 10 ml had been reached. The diurnal rhythm was assessed by individual curve fitting on the log scale and by cosinor analysis. A rhythm was present prepubertally and developed into a pattern similar to that of the adult rhythm by stage G3. The monthly rate of rise of ST was greatest at stage G4. A significant rise in ST levels was detectable immediately prior to an increase in MTV to 3 ml. This allowed earlier recognition of the clinical onset of puberty at testicular volume of 3 ml, which in this group occurred at 10.9 (SD 0.9) years. ST is a non-invasive and sensitive method for the serial monitoring of gonadal function in the prepubertal and adolescent boy.

Dexamethasone and spironolactone in the treatment of non-tumorous hyperandrogenism

To test the hypothesis that a combination therapy with dexamethasone and spironolactone in hirsute women with menstrual disorders due to non-tumorous hyperandrogenism might yield better results than monotherapy with spironolactone, we evaluated 25 women randomly assigned to dexamethasone-spironolactone (n = 15) and spironolactone (n = 10) groups. The Ferriman-Gallwey score and hormonal levels (LH, FSH, PRL, serum testosterone, androstenedione, dehydroepiandrosterone sulfate, estradiol, estrone and salivary testosterone) were determined before and after 6 months of therapy. There were comparable results, with a significant drop in the Ferriman-Gallwey score, in serum androstenedione and estrone concentrations and in salivary testosterone levels in both groups. The only difference between the two groups after therapy was a significant fall in serum dehydroepiandrosterone levels in patients treated with the combination therapy. The results indicate that the combination therapy with spironolactone and dexamethasone presents no real advantage over therapy with spironolactone alone, for the initial treatment of non-tumorous hyperandrogenism.

Salivary testosterone levels in males from the Ituri Forest of Zaïre.

Morning and evening testosterone levels were measured in the saliva of Efe pygmies (N = 11) and Lese villagers (N = 18) living in the Ituri Forest of northeast Zaïre and compared with levels in Boston controls (N = 10). With one exception, levels in the individual Zaïrois subjects fall within the normal ranges reported for Western clinical populations. Daily variation in the Zaïrois subjects (a.m./p.m. ratio = 1.32 for Efe, 1.22 for Lese) is also comparable to both the Boston controls (1.61) and values reported by other researchers for Western subjects. Average morning levels for the Zairois subjects (420 pmol/liter for Efe, 341 pmol/liter for Lese), however, fall significantly below the average for the Boston subjects (589 pmol/liter; Efe, P <0.05; Lese, P <0.01). A correlation between morning testosterone level and height is observed for the Lese sample (r=0.76, P <0.005). Similar correlations have not been reported for Western subjects. Possible roles of acute and chronic environmental conditions in generating these observations are noted. This study demonstrates the potential utility of salivary steroid assays for investigating questions related to male gonadal function under field conditions.

Interpretation of the discrepancy observed between plasma free and salivary testosterone levels in man

The differences observed between plasma free and saliva testosterone levels do not result from methodological artefacts. We postulate that androgens metabolism in salivary glands modulates saliva testosterone levels both in men and women. In women, the “excess” of saliva testosterone (compared to the calculated free testosterone concentration), could be due to conversion of androstenedione in the salivary glands. The rate of this transformation is exaggerated in hirsute patients resulting in a significantly higher excess of saliva testosterone. In men, on the contrary, a “deficit” in saliva testosterone is observed suggesting testosterone transformation in salivary glands. This deficit is more marked in impotent men and appears to be reversed by testosterone administration. Saliva testosterone levels do not merely reflect plasma free hormone concentrations but also afford potentially useful Information on androgens metabolism.

122 THE ASSESSMENT OF GONADAL FUNCTION IN XXY AND XYY BOYS USING SERIAL SALIVARY TESTOSTERONE SAMPLING

Salivary Testosterone (ST) levels have been measured in boys from the Edinburgh Longitudinal Growth Study. 84 controls (46, XY) aged 7-16 yrs, 7 47, XYY and 16 47, XXY boys (aged 6-19 yrs) identified by cytogenetic screening of the newborn, collected six samples over one day (9am-9pm) for 4 months, then 8 and 16 months later. ST concentrations were measured by RIA# and correlated closely (r=0.88) with 18 matched plasma samples. Normal ranges were constructed by individual curve fitting. A diurnal rhythm was present prepubertally, but developed fully by G3 (9am +76%; 9pm - 32% of daily mean). ST profiles from the XYY boys did not differ from the controls. The mean ST level of prepubertal XXY boys (33.5pmol/l) was higher (p 90th centile (37.5pmol/l). 24 hour urinary adrenal androgen metabolites in these boys were analysed by GLC at Ninewells Hospital and were not elevated. The mean ST of 6 XXY boys at G5PH5 (119.8pmol/l) was lower than the normal range (149.3-235.4pmol/l). Four received oral testosterone undecanoate (TU). Repeating ST profiles allowed individual dosage adjustment (40-120mg daily). Early results show TU therapy to be associated with a reduction in skinfold thicknesses, but not to prevent transient gynaecomastia. Measurement of ST is a sensitive non-invasive method for serial monitoring of gonadal function. #Walker RF et al. Int. J. Androl. 1980; 3: 105.

Salivary testosterone levels in infertile men.

Salivary testosterone levels were measured in 18 normal men, 29 oligospermic and six azoospermic subjects, using a specific and sensitive radioimmunoassay (RIA). There was a significant reduction (P less than 0.001) in salivary testosterone levels in the group of oligospermic (0.266 +/- 0.086 nmol/l) and azoospermic (0.234 +/- 0.055 nmol/l) subjects when compared with controls (0.348 +/- 0.070 nmol/l). A good correlation was found between salivary and plasma testosterone levels in normal (r = 0.62, P less than 0.01) and infertile men (r = 0.58, P less than 0.01). This study demonstrates that salivary testosterone levels, a non-invasive means of sample collection, may be used for evaluation of androgen status in male infertility.

Hormonal profile and serum zinc levels in uraemic men with gonadal dysfunction undergoing haemodialysis

Serum gonadal hormones, gonadotrophins and zinc levels were studied in thirteen men aged 29–62 yr with chronic renal failure undergoing haemodialysis. All patients had decreased libido and impotence. Serum testosterone levels in patients (18.5 ±1.3 (sem) nmol/l) were significantly lower ( p < 0.05) than in the control group (24.1 ± 2.2 (sem) nmol/l) although salivary testosterone levels were strictly within the normal range. Mean serum 17-β-oestradiol and luteinizing hormone levels (0.19 ± 0.03 (sem) nmol/l, and 57.4 ± 13.1 (sem) IU/l, respectively) were significantly higher ( p < 0.05 and p < 0.005, respectively) than in the control group (0.11 ± 0.02 (sem) nmol/l and 14.8 ± 1.9 (sem) IU/l, respectively). Mean progesterone and follicle-stimulating hormone levels in patients were not significantly different from those of control subjects. Mean prolactin values in patients (1,019 ± 285 (sem) mIU/l) were significantly higher ( p < 0.01) than in the control group (211 ± 24 (sem) ml U/l). Serum prolactin levels in five patients were extremely high (above 1,200 mIU/l). There was no statistically significant difference in serum zinc levels between patients and controls. As salivary testosterone is normal, it seems that hyperprolactinaemia and raised serum 17-β-oestradiol levels may be responsible, at least in part, for sexual dysfunction in male patients with chronic renal failure receiving haemodialysis.

Salivary testosterone levels in normal and testosterone treated monkeys

Testosterone concentrations in saliva and matched serum samples were measured by radio-immunoassay, in normal and testosterone treated adult male cynomolgus monkeys ( Macaca fascicularis) and in untreated rhesus monkeys ( Macaca mulatta). Saliva and serum samples were collected under ketamine anaesthesia. In 4 cynomolgus monkeys, the mean basal testosterone levels were 195 ± 22 pmol/1 in saliva and 24 ± 2 nmol/1 in serum ( n = 17). The salivary testosterone corresponded to 0.9 ± 0.1% of the serum testosterone concentration. In 5 rhesus monkeys the mean testosterone concentrations were 147 ± 10 pmol/1 in saliva and 17 ± 2 nmol/1 in matched serum samples with a percent ratio of 1.6 ± 0.3 ( n = 15). Following a single i.m. injection of 50mg testosterone propionate to 4 monkeys, both salivary and serum testosterone levels increased promptly and in parallel. The salivary testosterone levels correlated well with the serum testosterone values. The study suggests that, as in the human, determination of salivary testosterone can be used as an index of free testosterone in this animal. Moreover, the monkey can be used as a model for studies in the human involving monitoring of salivary testosterone.

Haemodialysis and testicular function.

Gonadal dysfunction in men with chronic renal failure is well established. However, the effect of haemodialysis on the function of the testis has not been studied in detail, so we have investigated the effect of haemodialysis by measuring the plasma levels of testosterone and dihydrotestosterone, SHBG binding capacity and salivary levels of testosterone. Plasma levels of testosterone, dihydrotestosterone and salivary testosterone levels were significantly lower in patients on haemodialysis than in controls. There was also a reduction in 5 alpha-reductase activity as evidenced by a reduced 5 alpha DHT/T ratio. SHBG levels were comparable to those found in eugonadal men. No differences were found in the parameters studied before and after 6 h haemodialysis. It is concluded that haemodialysis is not of obvious benefit to gonadal function.

Testosterone Concentrations in Human Seminal Plasma and Saliva and its Correlation With Non-Protein-Bound and Total Testosterone Levels in Serum

A sensitive, specific and precise non-chromatographic method for the radioimmunoassay of testosterone in human seminal plasma and saliva from adult and pubertal males is described, and the values compared to total and non-protein-bound testosterone levels in serum. There was a significant correlation between salivary and serum-free levels of testosterone (r = 0.75, P less than 0.001, n = 67) whilst the correlation of serum levels of total testosterone with free as well as with salivary testosterone levels was weaker (r = 0.63 and 0.64, respectively). The salivary and serum levels of free testosterone showed better correlation with the stage of puberty than did the serum levels of total testosterone. Further evidence for a correlation between salivary and serum levels of free testosterone was obtained following oral administration of testosterone undecanoate, as this treatment increased the mean concentration of serum total testosterone after 3 h by 82%, but increased salivary and serum levels of free testosterone by only 30% and 20%, respectively. The coefficient of correlation between serum levels of total testosterone and seminal plasma testosterone was 0.73 (P less than 0.001), whilst the correlation between levels of serum-free testosterone with both salivary and seminal plasma levels of testosterone was statistically non-significant. Our observations on salivary testosterone are in accordance with the diffusion of non-protein-bound steroids into peripheral tissues, and consequently into their secretions. This model, however, does not appear to be applicable to the sex accessory glands.

Sex hormone-binding globulin and saliva testosterone levels in men with androgenetic alopecia.

Sex hormone binding globulin (SHBG), plasma testosterone and saliva testosterone were measured in sixty-four men with androgenetic alopecia and in forty males within the same age range without alopecia. There was a significant reduction in SHBG levels in bald men, compared with controls. Plasma testosterone levels were not raised in bald men, but their salivary testosterone levels were significantly higher than in controls.

SALIVARY TESTOSTERONE: RELATIONSHIP TO UNBOUND PLASMA TESTOSTERONE IN NORMAL AND HYPERANDROGENIC WOMEN

A sensitive radioimmunoassay (RIA) was used to measure salivary testosterone levels in normal women, in patients with polycystic ovaries (PCO), and in women with hirsutism. There was a highly significant correlation (r = 0.79, P less than 0.001) between the concentration of testosterone in saliva [12.3 +/- 7.8 (SD) pg/ml] and the concentration of unbound testosterone in plasma (5.2 +/- 3.1 pg/ml) in matched samples collected from 56 women including normals, patients with clinical signs of hyperandrogenism, and women treated with a combination of cyproterone acetate (CA) and ethinyl oestradiol (EE). The unbound plasma testosterone was measured in the dialysate directly using a sensitive RIA. Salivary and plasma testosterone levels in patients with PCO (20.6 +/- 8.5 and 626 +/- 187 pg/ml respectively, n = 14) and in those with hirsutism (13.9 +/- 5.6 and 421 +/- 170 pg/ml, n = 30) were significantly higher (P less than 0.001) than levels in normal women (7.7 +/- 2.6 and 196 +/- 68 pg/ml, n = 36). Treatment for 3 months with CA and EE resulted in a decrease (mean 68%) in salivary testosterone levels in all patients studied (n = 15), but the suppression of plasma testosterone (mean 34%) was not observed in all cases. It is concluded that measurement of salivary testosterone gives a useful indication of levels of biologically available androgen in hyperandrogenic women, before and during CA/EE therapy.